Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/35149

Registo completo
Campo DCValorIdioma
dc.contributor.authorRodrigues, L. R.por
dc.date.accessioned2015-05-13T22:35:25Z-
dc.date.available2015-05-13T22:35:25Z-
dc.date.issued2015-07-
dc.identifier.citationRodrigues, L. R., Microbial surfactants: fundamentals and applicability in the formulation of nano-sized drug delivery vectors. Journal of Colloid and Interface Science, 449, 304-316, 2015por
dc.identifier.issn0021-9797por
dc.identifier.urihttps://hdl.handle.net/1822/35149-
dc.description.abstractMicrobial surfactants, so-called biosurfactants, comprise a wide variety of structurally distinct amphipathic molecules produced by several microorganisms. Besides exhibiting surface activity at the interfaces, these molecules present powerful characteristics including high biodegradability, low toxicity and special biological activities (e.g. antimicrobial, antiviral, anticancer, among others), that make them an alternative to their chemical counterparts. Several medical-related applications have been suggested for these molecules, including some reports on their potential use in the formulation of nano-sized drug delivery vectors. However, despite their promises, due to the generalized lack of knowledge on microbial surfactants phase behavior and stability under diverse physicochemical conditions, these applications remain largely unexplored, thus representing an exciting field of research. These nano-sized vectors are a powerful approach towards the current medical challenges regarding the development of efficient and targeted treatments for several diseases. In this review, a special emphasis will be given to nanoparticles and microemulsions. Nanoparticles are very auspicious as their size, shape and stability can be manipulated by changing the environmental conditions. On the other hand, the easiness of formulation, as well as the broad possibilities of administration justifies the recent popularity of the microemulsions. Notwithstanding, both vector types still require further developments to overcome some critical limitations related with toxicity and costs, among others. Such developments may include the search for other system components, as the microbial surfactants, that can display improved features.por
dc.description.sponsorshipThe author acknowledges the financial support from the Strategic Project PEst-OE/EQB/LA0023/2013 and project ref. RECI/BBB-EBI/0179/2012 (project number FCOMP-01-0124-FEDER-027462) funded by Fundacao para a Ciencia e a Tecnologia.por
dc.language.isoengpor
dc.publisherElsevier Ltd.por
dc.rightsopenAccesspor
dc.subjectBiosurfactantspor
dc.subjectMicroemulsionspor
dc.subjectNanoparticlespor
dc.subjectDrug delivery systemspor
dc.subjectSelf-aggregationpor
dc.titleMicrobial surfactants: fundamentals and applicability in the formulation of nano-sized drug delivery vectorspor
dc.typearticle-
dc.peerreviewedyespor
dc.relation.publisherversionhttp://www.journals.elsevier.com/journal-of-colloid-and-interface-sciencepor
dc.commentsCEB19789por
sdum.publicationstatuspublishedpor
oaire.citationStartPage304por
oaire.citationEndPage316por
oaire.citationConferencePlaceUnited States-
oaire.citationTitleJournal of Colloid and Interface Sciencepor
oaire.citationVolume449por
dc.date.updated2015-05-06T10:46:35Z-
dc.identifier.eissn1095-7103-
dc.identifier.doi10.1016/j.jcis.2015.01.022por
dc.identifier.pmid25655712por
dc.subject.wosScience & Technologypor
sdum.journalJournal of Colloid and Interface Sciencepor
Aparece nas coleções:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
document_19789_1.pdf1,15 MBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID